Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.75 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.66 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 2/20 | 0.58 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.58 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29822827 | 1.00 | GAA (0.75) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| Bendazol SCHEMBL309393 | 0.86 | GAA (1.00) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| Bendazol SCHEMBL29539948 | 0.86 | GAA (1.00) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| SCHEMBL27902885 | 0.85 | GAA (0.68) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| SCHEMBL29823043 | 0.85 | GAA (0.77) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| SCHEMBL22356617 | 0.85 | GAA (0.77) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| Bendazol SCHEMBL27823120 | 0.84 | GAA (0.96) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| Bendazol SCHEMBL15015931 | 0.84 | GAA (0.96) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| SCHEMBL4035157 | 0.83 | GAA (0.75) | GAAGRIN1GRIN2BRAB9ANPC1 | |
| SCHEMBL721860 | 0.83 | GAA (0.75) | GAAGRIN1GRIN2BRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12144253-B2 | Compound and an organic semiconducting layer, an organic electronic device and a display or lighting device comprising the same | NOVALED GMBH (DE) | 2024-11-12 | — | — | US | disclosed |
| EP-3696180-B1 | COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE AND A DISPLAY OR LIGHTING DEVICE COMPRISING THE SAME | NOVALED GMBH (DE) | 2023-10-04 | — | — | EP | disclosed |
| EP-3696180-B1 | COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE AND A DISPLAY OR LIGHTING DEVICE COMPRISING THE SAME | NOVALED GMBH (DE) | 2023-10-04 | — | — | EP | disclosed |
| CN-113512038-B | Benzo [4,5] imidazo [1,2-a ] pyridine derivative and preparation method and application thereof | 华南师范大学 | 2022-08-05 | — | — | CN | disclosed |
| US-20220149290-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device and a Display or Lighting Device Comprising the Same | NOVALED GMBH (DE) | 2022-05-12 | — | — | US | disclosed |
| CN-113631556-A | Compound, and organic semiconductor layer, organic electronic device, and display device or lighting device comprising same | 诺瓦尔德股份有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-113512038-A | Benzo [4,5] imidazo [1,2-a ] pyridine derivative and preparation method and application thereof | 华南师范大学 | 2021-10-19 | — | — | CN | disclosed |
| EP-3696180-A1 | COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE AND A DISPLAY OR LIGHTING DEVICE COMPRISING THE SAME | Novaled GmbH (DE) | 2020-08-19 | — | — | EP | disclosed |
| EP-3696180-A1 | COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE AND A DISPLAY OR LIGHTING DEVICE COMPRISING THE SAME | Novaled GmbH (DE) | 2020-08-19 | — | — | EP | disclosed |
| EP-3188577-B1 | METHOD FOR FORMING ORGANIC COATING ON COPPER SURFACE | ROHM & HAAS ELECT MAT (US) | 2019-01-30 | — | — | EP | disclosed |
| US-7754105-B2 | Water-soluble preflux and usage of the same | SHIKOKU CHEMICALS CORPORATION (JP) | 2010-07-13 | — | — | US | disclosed |
| US-20080318070-A1 | Water-Soluble Preflux and Usage of the Same | SHIKOKU CHEMICALS CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| EP-1886759-A1 | WATER-SOLUBLE PREFLUX AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2008-02-13 | — | — | EP | disclosed |
| US-5874501-A | POLY(P-HYDROXYSTYRENE) WITH AROMATIC MOIETY AND ALIPHATIC MOIETY WITH INORGANIC OXIDE | KEEHAN DONALD J (US) | 1999-02-23 | — | — | US | disclosed |
| EP-0407554-B1 | METALLIC OXIDE-OXIRANE POLYMERS AND PREPOLYMERS | KEEHAN DONALD J (US) | 1997-09-17 | — | — | EP | disclosed |
| WO-1997031047-A1 | MULTI-FUNCTIONAL OXIRANE POLYMERS | KEEHAN DONALD J (US) | 1997-08-28 | — | — | WO | disclosed |
| US-5658996-A | A LIQUID POLYEPOXIDE PREPOLYMER THE REACTION PRODUCT OF A TRISHYDROXYPHENYL, AN AROMATIC DIGLYCIDYL ETHER AND METAL OXIDE; CURABLE, LOW VISCOSITY; FORMED POLYEPOXIDE IS HEAT AND CHEMICAL RESISTANCE, ELONGATION, TOUGHNESS | KEEHAN DONALD J (US) | 1997-08-19 | — | — | US | disclosed |
| US-5169912-A | Hydrolyzable oxygen bonding with epoxide; silica, titania; high performance coatings, adhesives | KEEHAN DONALD J (US) | 1992-12-08 | — | — | US | disclosed |
| US-5026816-A | Reaction product of diglycidyl ether of (bisphenol a or resorcinol) with metallic oxide in presence of imidazole catalyst | KEEHAN DONALD J (US) | 1991-06-25 | — | — | US | disclosed |
| US-4880892-A | PHOSPHONIUM OR PHOSPHORANE CATALYST, PROTECTIVE COATINGS | CIBA-GEIGY CORPORATION (US) | 1989-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12144253-B2 | Compound and an organic semiconducting layer, an organic electronic device and a display or lighting device comprising the same | OCIAD1, AOX1, OCIAD2 | GAA 2507/4885GRIN1 1672/4885GRIN2B 1448/4885 |
| US-20220149290-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device and a Display or Lighting Device Comprising the Same | OCIAD1, AOX1, OCIAD2 | GAA 2507/4885GRIN1 1672/4885GRIN2B 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.